LENTIWORKS TECHNICAL FIELD GUIDE

Lentiviral Vector Development Assessment

What to Review Before Scaling Your Process

A practical technical framework for evaluating process performance, vector quality, analytical strategy, reproducibility, and scale-up readiness before committing additional resources.

Free PDF · 10 pages · Fillable scorecard · No email required

A technical development framework—not regulatory advice, a validation protocol, or a determination of clinical suitability.

Cover of the LentiWorks Lentiviral Vector Development Assessment DEVELOPMENT ASSESSMENT

WHAT’S INSIDE

Evidence first.
Scale second.

For scientists, CMC leaders and technical founders who need to decide what to test next—not just what to measure.

  1. 02–03

    Define readiness

    Five questions to resolve and a fillable, evidence-based scorecard across six development areas.

  2. 04–05

    Understand the process

    Product definition, upstream dependencies and a downstream recovery map that distinguishes concentration from total functional yield.

  3. 06–07

    Connect measurements to decisions

    Physical versus functional titer, analytical disagreement and focused experiments that reduce uncertainty.

  4. 08–09

    Pressure-test the next step

    A scale-up risk map, technology-transfer checklist and ten signals that your evidence may not yet support scaling.

USE IT IN YOUR NEXT DEVELOPMENT REVIEW

What experiment would reduce the most uncertainty?

Read the framework, complete the scorecard with your team, and record the evidence behind each status. Prioritize the weakest link rather than averaging away a development gap.

The scorecard can be printed or completed in a PDF reader that supports form fields. Save your completed copy in that reader; browser support varies.

AN INDEPENDENT TECHNICAL PARTNER

Have an LV development problem you need to pressure-test?

LentiWorks can review your process, data, analytical strategy, and development objectives to identify the highest-value technical questions and next steps.

Independent technical consulting—not a CDMO or a manufacturer of clinical-grade vector.

Discuss your program